Multidimensional characteristics, prognostic role, and preoperative prediction of peritoneal sarcomatosis in retroperitoneal sarcoma
Creators
- 1. Peking University
- 2. Peking University Cancer Hospital
Description
Background Peritoneal sarcomatosis (PS) could occur in patients with retroperitoneal sarcomas (RPS). This study aimed to expand the understanding of PS on its characteristics and prognostic role, and develop a nomogram to predict its occurrence preoperatively. Methods Data of 211 consecutive patients with RPS who underwent surgical treatment between 2011 and 2019 was retrospectively reviewed. First, the clinicopathological characteristics of PS were summarized and analyzed. Second, the disease-specific survival (DSS) and recurrence-free survival (RFS) of patients were analyzed to evaluate the prognostic role of PS. Third, preoperative imaging, nearly the only way to detect PS preoperatively, was combined with other screened risk factors to develop a nomogram. The performance of the nomogram was assessed. Results Among the 211 patients, 49 (23.2%) patients had PS with an incidence of 13.0% in the primary patients and 35.4% in the recurrent patients. The highest incidence of PS occurred in dedifferentiated liposarcoma (25.3%) and undifferentiated pleomorphic sarcoma (25.0%). The diagnostic sensitivity of the preoperative imaging was 71.4% and its specificity was 92.6%. The maximum standardized uptake value (SUVmax) was elevated in patients with PS (P<0.001). IHC staining for liposarcoma revealed that the expression of VEGFR-2 was significantly higher in the PS group than that in the non-PS group (P = 0.008). Survival analysis (n =196) showed significantly worse DSS in the PS group than in non-PS group (median: 16.0 months vs. not reached, P < 0.001). In addition, PS was proven as one of the most significant prognostic predictors of both DSS and RFS by random survival forest algorithm. A nomogram to predict PS status was developed based on preoperative imaging combined with four risk factors including the presentation status (primary vs. recurrent), ascites, SUVmax, and tumor size. The nomogram significantly improved the diagnostic sensitivity compared to preoperative imaging alone (44/49, 89.8% vs. 35/49, 71.4%). The C-statistics of the nomogram was 0.932, and similar C-statistics (0.886) was achieved at internal cross-validation. Conclusion PS is a significant prognostic indicator for RPS, and it occurs more often in recurrent RPS and in RPS with higher malignant tendency. The proposed nomogram is effective to predict PS preoperatively.
Translated Descriptions
Translated Description (Arabic)
يمكن أن يحدث الساركوما البريتونية الخلفية (PS) في المرضى الذين يعانون من الساركوما خلف الصفاق (RPS). هدفت هذه الدراسة إلى توسيع فهم PS لخصائصه ودوره التنبئي، وتطوير مخطط للتنبؤ بحدوثه قبل الجراحة. طرق تمت مراجعة بيانات 211 مريضًا متتاليًا يعانون من RPS الذين خضعوا للعلاج الجراحي بين عامي 2011 و 2019 بأثر رجعي. أولاً، تم تلخيص وتحليل الخصائص السريرية المرضية لمرض باركنسون. ثانيًا، تم تحليل البقاء على قيد الحياة الخاص بالمرض (DSS) والبقاء على قيد الحياة بدون تكرار (RFS) للمرضى لتقييم الدور التنبئي لـ PS. ثالثًا، تم الجمع بين التصوير قبل الجراحة، وهو الطريقة الوحيدة تقريبًا للكشف عن متلازمة ما بعد الصدمة قبل الجراحة، وعوامل الخطر الأخرى التي تم فحصها لتطوير مخطط الترقيم. تم تقييم أداء الرسم البياني. النتائج من بين 211 مريضًا، كان 49 مريضًا (23.2 ٪) يعانون من متلازمة النخاع الشوكي مع حدوث 13.0 ٪ في المرضى الأساسيين و 35.4 ٪ في المرضى المتكررين. حدثت أعلى نسبة للإصابة بساركوما شحمية غير متمايزة (25.3 ٪) وساركوما متعددة الأشكال غير متمايزة (25.0 ٪). بلغت الحساسية التشخيصية للتصوير قبل الجراحة 71.4 ٪ وكانت خصوصيته 92.6 ٪. تم رفع الحد الأقصى لقيمة الامتصاص الموحدة (SUVmax) في المرضى الذين يعانون من PS (P<0.001). كشف تلوين IHC للساركوما الشحمية أن التعبير عن VEGFR -2 كان أعلى بكثير في مجموعة PS منه في المجموعة غير PS (P = 0.008). أظهر تحليل البقاء على قيد الحياة (العدد =196) متلازمة داون أسوأ بكثير في مجموعة متلازمة ما بعد الصدمة من المجموعة غير PS (المتوسط: 16.0 شهرًا مقابل لم يتم الوصول إليه، P < 0.001). بالإضافة إلى ذلك، تم إثبات PS كواحد من أهم التنبؤات التنبؤية لكل من DSS و RFS من خلال خوارزمية غابة البقاء العشوائية. تم تطوير مخطط للتنبؤ بحالة متلازمة ما بعد الصدمة بناءً على التصوير قبل الجراحة جنبًا إلى جنب مع أربعة عوامل خطر بما في ذلك حالة العرض التقديمي (الأولي مقابل المتكرر)، والاستسقاء، و SUVmax، وحجم الورم. حسّن مخطط القياس بشكل كبير من الحساسية التشخيصية مقارنة بالتصوير قبل الجراحة وحده (44/49، 89.8 ٪ مقابل 35/49، 71.4 ٪). كانت إحصائيات C للرسم البياني 0.932، وتم تحقيق إحصائيات C مماثلة (0.886) عند التحقق المتبادل الداخلي. الاستنتاج ملاحظة: هو مؤشر تنبؤي مهم لـ RPS، ويحدث في كثير من الأحيان في RPS المتكررة وفي RPS مع ميل خبيث أعلى. الرسم البياني المقترح فعال للتنبؤ بمتلازمة ما بعد الصدمة قبل الجراحة.Translated Description (English)
Background Peritoneal sarcomatosis (PS) could occur in patients with retroperitoneal sarcomas (RPS). This study aimed to expand the understanding of PS on its characteristics and prognostic role, and develop a nomogram to predict its occurrence preoperatively. Methods Data of 211 consecutive patients with RPS who underwent surgical treatment between 2011 and 2019 was retrospectively reviewed. First, the clinicopathological characteristics of PS were summarized and analyzed. Second, the disease-specific survival (DSS) and recurrence-free survival (RFS) of patients were analyzed to evaluate the prognostic role of PS. Third, preoperative imaging, nearly the only way to detect PS preoperatively, was combined with other screened risk factors to develop a nomogram. The performance of the nomogram was assessed. Results Among the 211 patients, 49 (23.2%) patients had PS with an incidence of 13.0% in the primary patients and 35.4% in the recurrent patients. The highest incidence of PS occurred in dedifferentiated liposarcoma (25.3%) and undifferentiated pleomorphic sarcoma (25.0%). The diagnostic sensitivity of the preoperative imaging was 71.4% and its specificity was 92.6%. The maximum standardized uptake value (SUVmax) was elevated in patients with PS (P<0.001). IHC staining for liposarcoma revealed that the expression of VEGFR-2 was significantly higher in the PS group than in the non-PS group (P = 0.008). Survival analysis (n =196) showed significantly worse DSS in the PS group than in non-PS group (median: 16.0 months vs. not reached, P < 0.001). In addition, PS was proven as one of the most significant prognostic predictors of both DSS and RFS by random survival forest algorithm. A nomogram to predict PS status was developed based on preoperative imaging combined with four risk factors including presentation status (primary vs. recurrent), ascites, SUVmax, and tumor size. The nomogram significantly improved the diagnostic sensitivity compared to preoperative imaging alone (44/49, 89.8% vs. 35/49, 71.4%). The C-statistics of the nomogram was 0.932, and similar C-statistics (0.886) was achieved at internal cross-validation. Conclusion PS is a significant prognostic indicator for RPS, and it occurs more often in recurrent RPS and in RPS with higher malignant tendency. The proposed nomogram is effective to predict PS preoperatively.Translated Description (French)
Contexte Péritonéal sarcomatose (PS) could occur chez les patients atteints de sarcomes rétropéritonéaux (RPS). This study aimed to expand the understanding of PS on its characteristics and pronostic role, and develop a nomogram to predict its occurrence preoperatively. Methods Data of 211 consecutive patients with RPS who underwent surgical treatment between 2011 and 2019 was retrospectively reviewed. First, the clinicopathological characteristics of PS were summarized and analyszed. Second, the disease-specific survival (DSS) and recurrence-free survival (RFS) of patients were analyszed to evaluate the pronostic role of PS. Third, preoperative imaging, nearly the only way to detect PS preoperatively, was combined with other screened risk factors to develop a nomogram. The performance of the nomogram was assessed. Résultats parmi les 211 patients, 49 (23,2 %) patients had PS avec une incidence de 13,0 % chez les patients primaires et de 35,4 % chez les patients récurrents. The highest incidence of PS occurred in dedifferentiated liposarcoma (25,3 %) and undifferentiated pleomorphic sarcoma (25,0 %). The diagnostic sensitivity of the preoperative imaging was 71.4 % and its specity was 92.6 %. The maximum standardized uptake value (SUVmax) was elevated in patients with PS (P< ;0.001). IHC staining for liposarcoma revealed that the expression of VEGFR-2 was significantly higher in the PS group than that in the non-PS group (P = 0,008). Survival analysis (n =196) showed significantly worse DSS in the PS group than in non-PS group (median : 16.0 months vs. not reached, P < 0.001). En outre, PS was proven as one of the most significant pronostic predictors of both DSS and RFS by random survival forest algorithm. A nomogram to predict PS status was developed based on preoperative imaging combined with four risk factors including the presentation status (primary vs. recurrent), ascites, SUVmax, and tumor size. The nomogram significantly improved the diagnostic sensitivity compared to preoperative imaging alone (44/49, 89.8% vs. 35/49, 71.4%). The C-statistics of the nomogram was 0.932, and similar C-statistics (0.886) was achieved at internal cross-validation. Conclusion PS is a significant pronostic indicator for RPS, and it occurs more often in recurrent RPS and in RPS with higher malignant tendency. The proposed nomogram is effective to predict PS preoperatively.Translated Description (Spanish)
Antecedentes Peritoneal sarcomatosis (PS) could occur in patients with retroperitoneal sarcomas (RPS). This study aimed to expand the understanding of PS on its characteristics and prognostic role, and develop a nomogram to predict its occurrence preoperatively. Methods Data of 211 consecutive patients with RPS who underwent surgical treatment between 2011 and 2019 was retrospectively reviewed. First, the clinicopathological characteristics of PS were summarized and analyzed. Second, the disease-specific survival (DSS) and recurrence-free survival (RFS) of patients were analyzed to evaluate the prognostic role of PS. Third, preoperative imaging, nearly the only way to detect PS preoperatively, was combined with other screened risk factors to develop a nomogram. The performance of the nomogram was assessed. Results Among the 211 patients, 49 (23.2%) patients had PS with an incidence of 13.0% in the primary patients and 35.4% in the recurrent patients. The highest incidence of PS occurred in dedifferentiated liposarcoma (25,3%) and undifferentiated pleomorphic sarcoma (25,0%). The diagnos sensitivity of the preoperative imaging was 71.4% and its specity was 92.6%. The maximum standardzed uptake value (SUVmax) was elevated in patients with PS (P<0.001). IHC staining for liposarcoma revealed that the expression of VEGFR-2 was significantly higher in the PS group than that in the non-PS group (P = 0.008). Survival analysis (n =196) showed significantly worse DSS in the PS group than in non-PS group (median: 16.0 months vs. not reached, P < 0.001). In addition, PS was proven as one of the most significant prognostic predictors of both DSS and RFS by random survival forest algorithm. A nomogram to predict PS status was developed based on preoperative imaging combined with four risk factors including the presentation status (primary vs. recurrent), ascites, SUVmax, and tumor size. The nomogram significantly improved the diagnostic sensitivity compared to preoperative imaging alone (44/49, 89.8% vs. 35/49, 71.4%). The C-statistics of the nomogram was 0.932, and similar C-statistics (0.886) was achieved at internal cross-validation. Conclusion PS is a significant prognostic indicator for RPS, and it occurs more often in recurrent RPS and in RPS with higher malignant tendency. The proposed nomogram is effective to predict PS preoperatively.Files
pdf.pdf
Files
(7.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:76c7713ae06d1238f73de8c366c73ece
|
7.8 MB | Preview Download |
Additional details
Additional titles
- Translated title (Arabic)
- الخصائص متعددة الأبعاد، والدور التنبئي، والتنبؤ قبل الجراحة بالساركوما البريتونية في الساركوما خلف البريتونية
- Translated title (English)
- Multidimensional characteristics, prognostic role, and preoperative prediction of peritoneal sarcomatosis in retroperitoneal sarcoma
- Translated title (French)
- Multidimensional characteristics, pronostic role, and preoperative prediction of peritoneal sarcomatosis in retroperitoneal sarcoma
- Translated title (Spanish)
- Características multidimensionales, función pronóstica y predicción preoperativa de sarcomatosis peritoneal en sarcoma retroperitoneal
Identifiers
- Other
- https://openalex.org/W4307799306
- DOI
- 10.3389/fonc.2022.950418
References
- https://openalex.org/W1484901346
- https://openalex.org/W1491711548
- https://openalex.org/W1965541229
- https://openalex.org/W1983206829
- https://openalex.org/W1985629328
- https://openalex.org/W1991339484
- https://openalex.org/W2000234736
- https://openalex.org/W2032309786
- https://openalex.org/W2066102059
- https://openalex.org/W2067022325
- https://openalex.org/W2131937004
- https://openalex.org/W2136316780
- https://openalex.org/W2138031433
- https://openalex.org/W2234472895
- https://openalex.org/W2259955047
- https://openalex.org/W2293809486
- https://openalex.org/W2318872159
- https://openalex.org/W2598076193
- https://openalex.org/W2606819954
- https://openalex.org/W2747989445
- https://openalex.org/W2780636335
- https://openalex.org/W2789914446
- https://openalex.org/W2791396067
- https://openalex.org/W2808043936
- https://openalex.org/W2883504899
- https://openalex.org/W2890686358
- https://openalex.org/W2897062681
- https://openalex.org/W2944423827
- https://openalex.org/W2957992369
- https://openalex.org/W2973239156
- https://openalex.org/W3001620508
- https://openalex.org/W3015671971
- https://openalex.org/W3045176511
- https://openalex.org/W3135278199
- https://openalex.org/W3135644338
- https://openalex.org/W3150934866
- https://openalex.org/W3152510773
- https://openalex.org/W3164809424
- https://openalex.org/W3193131339
- https://openalex.org/W3209279572
- https://openalex.org/W3216047796
- https://openalex.org/W4214817334
- https://openalex.org/W4229072422
- https://openalex.org/W4248017777
- https://openalex.org/W4285719527
- https://openalex.org/W4292455959